From Pathogen to Infectious Disease Diagnosis: Rapid Genotyping Could Bring Ciprofloxacin Back for Gonorrhea Cases

Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the majority of gonorrhea cases still susceptible to it, sparing ceftriaxone as resistance climbs worldwide. Lao-Tzu Allan-Blitz, MD, MPH, offers insights into his work in this area.